| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.7B | $10.0B | $10.8B | $14.1B | $6.1B | $2.6B | $2.8B | $4.7B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | $0.2B | $0.4B | $0.5B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.8B | $0.8B | $0.9B | $1.3B | $1.2B | $1.4B | $1.4B | $2.6B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $-0.3B | $-0.4B | $-0.7B | $-0.2B | $-1.7B | $-0.2B | $0.9B | $0.3B |
| EPS (Basic) | — | — | — | — | — | — | — | — |
| EPS (Diluted) | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $14.2B | $16.3B | $20.9B | $27.9B | $25.0B | $24.6B | $23.4B | $31.8B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $1.4B | $2.6B | $3.0B | $2.3B | $1.7B | $3.8B | $2.7B | $1.7B |
| Total Liabilities | $10.8B | $11.7B | $14.8B | $18.4B | $15.7B | $13.7B | $10.5B | $20.4B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | — | — | — | — | — | — | $6.5B | $5.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-0.3B | $0.8B | $3.7B | $1.1B | $-0.4B | $-1.5B | $0.9B | $-1.4B |
| Investing Cash Flow | $-0.4B | $-0.2B | $-0.3B | $-0.3B | $-0.6B | $0.6B | $2.6B | $0.4B |
| Capital Expenditures | $0.3B | $0.3B | $0.3B | $0.3B | $0.2B | $0.3B | $0.3B | $1.0B |
| Financing Cash Flow | $-1.1B | $-1.3B | $-2.4B | $-0.3B | $-0.7B | $0.6B | $-0.2B | $0.7B |